Sander Dale A.

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 141%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Sander Dale A.'s trades of Humacyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-18
US Humacyte Inc (HUMA)
PlS Planned sale
52,283 -9.7%
376.51
US$2,500,861 		52,283 -9.7% 376.51 US$2,500,861
2026-05-18 2026-05-18
US Humacyte Inc (HUMA)
PrS Proposed sale
71,327
282.38
US$1,653,397 		71,327 282.38 US$1,653,397
2026-05-18 2026-05-18
US Humacyte Inc (HUMA)
PrS Proposed sale
60,096
57.86
US$1,331,241 		60,096 57.86 US$1,331,241
2025-04-14 2025-04-10
US Humacyte Inc (HUMA)
B Purchase
20,000 +97.1%
1.53
US$30,600 		20,000 +97.1% 1.53 US$30,600
2024-08-29 2024-08-27
US Humacyte Inc (HUMA)
S Sale
39,389 -95.2%
6.68
US$263,119 		39,389 -95.2% 6.68 US$263,119
2024-08-27 2024-08-27
US Humacyte Inc (HUMA)
PrS Proposed sale
39,389
6.68
US$263,311 		39,389 6.68 US$263,311
2022-12-19 2022-12-16
US Humacyte Inc (HUMA)
B Purchase
20,000 +3333.3%
2.60
US$52,000 		20,000 +3333.3% 2.60 US$52,000
2022-05-18 2022-05-17
US Humacyte Inc (HUMA)
B Purchase
2,000 +inf%
4.53
US$9,060 		2,000 +inf% 4.53 US$9,060